| Gastro-intestinal system | |||||
|---|---|---|---|---|---|
| Gastro-intestinal system / Diarrhoea | |||||
| codeine phosphate | On Formulary | ||||
|
CODEINE PHOSPHATE
Chronic diarrhoea in children >12years without any respiratory issues |
|||||
|
The Association of Paediatric Palliative Medicine Formulary - 2017
see attached |
|||||
|
Paediatric Acute Sickle Cell Pain Pathway
See attached |
|||||
|
Paediatric Acute Pain Pathway
See attached |
|||||
| loperamide hydrochloride | On Formulary | ||||
|
NEONATAL FORMULARY VERSION 9 2016 BARTS HEALTH
|
|||||
|
LOPERAMIDE HYDROCHLORIDE
For chronic diarrhoea, irritable bowel where diarrhoea is predominant, and Short Bowel Syndrome |
|||||
|
The Association of Paediatric Palliative Medicine Formulary - 2017
see attached |
|||||
| Orodispersible tablet | |||||
| Imodium (McNeil Products Ltd) | On Formulary | ||||
|
NEONATAL FORMULARY VERSION 9 2016 BARTS HEALTH
see attached |
|||||
|
The Association of Paediatric Palliative Medicine Formulary - 2015
see attached |
|||||
| Gastro-intestinal system / Exocrine pancreatic insufficiency | |||||
| pancreatin | On Formulary | ||||
| Gastro-resistant capsule | |||||
| Creon (Viatris UK Healthcare Ltd) | On Formulary | ||||
| Gastro-resistant granules | |||||
| Creon (Viatris UK Healthcare Ltd) | On Formulary | ||||
| Gastro-intestinal system / Obesity | |||||
| orlistat | On Formulary | ||||
|
Orlistat Use in Childhood Obesity June 2015
|
|||||
| Gastro-intestinal system / Inflammatory bowel disease | |||||
| Vedolizumab | Hospital Only | ||||
|
Paediatric Ulcerative Colitis aged 3-18yrs
4th line treatment for paediatric ulcerative colitis (see attached algorithm below)
IV infusion loading dose 6mg/kg (max dose 300mg) at week 0, 2 and 6 then maintenance every 8 weeks. Blueteq form required for post-pubescent patients - check paediatric gastroenterology pharmacist is aware of all new patients starting treatment.
|
|||||
|
Paediatric Crohn's Disease
Post-pubescent patients only - Blueteq form required. Dosing as for ulcerative colitis. |
|||||
| adalimumab | On Formulary |
NICE TA373 NICE TA455 |
|||
|
ADALIMUMAB
Acute Crohn's disease in combination with Methotrexate or Azathioprine |
|||||
| azathioprine | Hospital Only | ||||
|
Difficult to Obtain Letter
see attached |
|||||
|
AZATHIOPRINE
CYTOTOXIC- tablets should not be broken, crushed or dissolved |
|||||
| balsalazide sodium | On Formulary | ||||
| BALSALAZIDE SODIUM | |||||
| beclometasone dipropionate | On Formulary | ||||
| budesonide | On Formulary | ||||
|
Budesonide Oral Viscous - For Eosinophilic Oesophagitis
Use budesonide nebuliser solution according to guidelines attached. |
|||||
| ciclosporin | On Formulary | ||||
|
CICLOSPORIN
For Hospital Use Only |
|||||
|
CICLOSPORIN
Ciclosporin - last line for Ulcerative Colitis not responsive to aminosalicylates & corticosteroids |
|||||
| Solution for infusion | |||||
| Sandimmun (Novartis Pharmaceuticals UK Ltd) | On Formulary | ||||
|
Sandimmun®
For Hospital Use Only - Unless part of SCG |
|||||
| golimumab | Off Formulary | ||||
| hydrocortisone | On Formulary | ||||
|
HYDROCORTISONE
|
|||||
| infliximab | On Formulary |
NICE TA187 NICE TA329 |
|||
|
Use of Infliximab in Inflammatory Bowel Disorders
see attached |
|||||
|
Bart's Health - Guidance for use of Infliximab
see attached |
|||||
|
INFLIXIMAB
Severe active Ulcerative Colitis/Crohn's disease |
|||||
| mercaptopurine | On Formulary | ||||
|
MERCAPTOPURINE
CYTOTOXIC- tablets should not be broken, crushed or dissolved |
|||||
| mesalazine | On Formulary | ||||
|
Drugs Used in Paediatric Inflammatory Bowel Disease
|
|||||
|
MESALAZINE
*Specify preparation by brand name* |
|||||
| Gastro-resistant tablet | |||||
| Salofalk (Dr. Falk Pharma UK Ltd) | On Formulary | ||||
|
NICE Guidance
*Specify preparation by brand name* |
|||||
| Modified-release granules | |||||
| Pentasa (Ferring Pharmaceuticals Ltd) | On Formulary | ||||
|
NICE Guidance
*Specify preparation by brand name* |
|||||
| Salofalk (Dr. Falk Pharma UK Ltd) | On Formulary | ||||
|
NICE Guidance
*Specify preparation by brand name* |
|||||
| Suppository | |||||
| Pentasa (Ferring Pharmaceuticals Ltd) | On Formulary | ||||
|
NICE Guidance
*Specify preparation by brand name* |
|||||
| Salofalk (Dr. Falk Pharma UK Ltd) | On Formulary | ||||
|
NICE Guidance
*Specify preparation by brand name* |
|||||
| methotrexate | On Formulary | ||||
|
Methotrexate
Hospital Use Only |
|||||
|
Monitoring blood values while on methotrexate
see attached |
|||||
|
Methotrexate Blood Monitoring Schedule
see attached |
|||||
|
METHOTREXATE
*ONCE WEEKLY dosing* |
|||||
| prednisolone | On Formulary | ||||
|
Cystic Fibrosis & non-CF Prescribing Pathway
see attached |
|||||
|
PREDNISOLONE
https://pathways.nice.org.uk/pathways/ulcerative-colitis https://pathways.nice.org.uk/pathways/crohns-disease
|
|||||
|
Prednisolone soluble tablets
Non-formulary (except long term patients with compliance issues) |
|||||
| sulfasalazine | On Formulary | ||||
|
SULFASALAZINE
Chronic bowel disorders (Ulcerative Colitis/ Crohn's disease) https://pathways.nice.org.uk/pathways/ulcerative-colitis
|
|||||
| Gastro-resistant tablet | |||||
| Sulfasalazine (Non-proprietary) | On Formulary | ||||
|
NICE Guidance
Chronic bowel disorders (Ulcerative Colitis/ Crohn's disease) |
|||||
| Oral suspension | |||||
| Sulfasalazine (Non-proprietary) | On Formulary | ||||
|
NICE Guidance
Chronic bowel disorders (Ulcerative Colitis/ Crohn's disease) |
|||||
| ustekinumab | Hospital Only |
NICE TA455 |
|||
|
Paediatric Crohn’s disease aged 3-18yrs
4th line treatment (see attached algorithm below) IV infusion loading dose 6mg/kg at week 0, followed by 8 weekly subcutaneous injection 45 mg (≤ 45kg) or 90 mg (>45kg) – weight dependent
DTC DEC 2021 Approval recevied to increase dosing frequency- schedule to 6 weekly for 1 patient/year and 4 weekly for 1 patient every 2 years |
|||||
|
July 2024 - Ustekinumab for refractory Crohn’s disease in pre-pubescent children
The licence has been extened for ustekinumab in children aged 6 years and over for paediatric plaque psoriasis, application of the Commissioning Medicines for Children policy also enables access to children aged 6 years and over with Crohn’s disease. |
|||||
| Gastro-intestinal system / Irritable bowel syndrome | |||||
| mebeverine hydrochloride | On Formulary | ||||
| Modified-release capsule | |||||
| Colofac MR (Viatris UK Healthcare Ltd) | On Formulary | ||||
| Oral suspension | |||||
| Mebeverine hydrochloride (Non-proprietary) | On Formulary | ||||
| peppermint oil | On Formulary | ||||
| Modified-release capsule | |||||
| Colpermin (Johnson & Johnson Ltd) | On Formulary | ||||
| Gastro-intestinal system / Bowel cleansing | |||||
| bisacodyl | On Formulary | ||||
|
Barts Health Guideline - Management of Constipation in Children
|
|||||
|
Difficult to Obtain Letter
|
|||||
|
The Association of Paediatric Palliative Medicine Formulary - 2017
see attached |
|||||
|
BISACODYL
|
|||||
| Gastro-resistant tablet | |||||
| Bisacodyl (Non-proprietary) | On Formulary | ||||
| docusate sodium | On Formulary | ||||
|
Paediatric Oncology Local Guidelines July 14
|
|||||
|
Barts Health Guideline - Management of Constipation in Children
|
|||||
|
The Association of Paediatric Palliative Medicine Formulary - 2017
see attached |
|||||
|
DOCUSATE SODIUM
|
|||||
| Oral solution | |||||
| Docusol (Typharm Ltd) | On Formulary | ||||
|
Paediatric Oncology Local Guidelines July 14
|
|||||
|
The Association of Paediatric Palliative Medicine Formulary - 2015
|
|||||
|
Barts Health Guideline - Management of Constipation in Children
|
|||||
| macrogol 3350 with anhydrous sodium sulfate, potassium chloride, sodium bicarbonate and sodium chloride | On Formulary | ||||
|
Barts Health Bowel Cleansing guidelines
BH Bowel Cleansing guidelines |
|||||
|
Bowel Cleansing
Bowel Cleansing |
|||||
| magnesium citrate with sodium picosulfate | On Formulary | ||||
|
The Association of Paediatric Palliative Medicine Formulary - 2017
see attached |
|||||
| meglumine amidotrizoate with sodium amidotrizoate | On Formulary | ||||
| Oral solution | |||||
| Gastrografin (Bayer Plc) | On Formulary | ||||
| Gastro-intestinal system / Constipation | |||||
| bisacodyl | On Formulary | ||||
|
Barts Health Guideline - Management of Constipation in Children
|
|||||
|
Difficult to Obtain Letter
|
|||||
|
The Association of Paediatric Palliative Medicine Formulary - 2017
see attached |
|||||
|
BISACODYL
|
|||||
| Gastro-resistant tablet | |||||
| Bisacodyl (Non-proprietary) | On Formulary | ||||
| docusate sodium | On Formulary | ||||
|
Paediatric Oncology Local Guidelines July 14
|
|||||
|
Barts Health Guideline - Management of Constipation in Children
|
|||||
|
The Association of Paediatric Palliative Medicine Formulary - 2017
see attached |
|||||
|
DOCUSATE SODIUM
|
|||||
| Oral solution | |||||
| Docusol (Typharm Ltd) | On Formulary | ||||
|
Paediatric Oncology Local Guidelines July 14
|
|||||
|
The Association of Paediatric Palliative Medicine Formulary - 2015
|
|||||
|
Barts Health Guideline - Management of Constipation in Children
|
|||||
| glycerol | On Formulary | ||||
|
The Association of Paediatric Palliative Medicine Formulary - 2017
see attached |
|||||
|
GLYCEROL
|
|||||
| Suppository | |||||
| Glycerol (Non-proprietary) | On Formulary | ||||
|
The Association of Paediatric Palliative Medicine Formulary - 2015
|
|||||
| ispaghula husk | On Formulary | ||||
|
ISPAGHULA HUSK
Irritable Bowel Syndrome if increased dietary fibre is required |
|||||
| lactulose | On Formulary | ||||
|
Paediatric Oncology Local Guidelines July 14
|
|||||
|
Barts Health Guideline - Management of Constipation in Children
|
|||||
|
Cystic Fibrosis & non-CF Prescribing Pathway
|
|||||
|
The Association of Paediatric Palliative Medicine Formulary - 2017
see attached |
|||||
|
LACTULOSE
https://www.nice.org.uk/guidance/cg99 |
|||||
| Oral solution | |||||
| Lactulose (Non-proprietary) | On Formulary | ||||
|
Paediatric Oncology Local Guidelines July 14
see attached |
|||||
|
Barts Health Guideline - Management of Constipation in Children
see attached |
|||||
|
The Association of Paediatric Palliative Medicine Formulary - 2015
see attached |
|||||
| macrogol 3350 with potassium chloride, sodium bicarbonate and sodium chloride | On Formulary | ||||
| senna | On Formulary | ||||
|
Paediatric Oncology Local Guidelines July 14
|
|||||
|
Barts Health Guideline - Management of Constipation in Children
|
|||||
|
The Association of Paediatric Palliative Medicine Formulary - 2017
see link |
|||||
|
SENNA
|
|||||
| sodium picosulfate | On Formulary | ||||
|
Paediatric Oncology Local Guidelines July 14
|
|||||
|
Barts Health Guideline - Management of Constipation in Children
|
|||||
|
Paediatric Oncology Local Guidelines July 14
see attached |
|||||
|
The Association of Paediatric Palliative Medicine Formulary - 2017
see attached |
|||||
|
SODIUM PICOSULFATE
|
|||||
| Oral solution | |||||
| Sodium picosulfate (Non-proprietary) | On Formulary | ||||
|
Paediatric Oncology Local Guidelines July 14
|
|||||
|
Barts Health Guideline - Management of Constipation in Children
see attached |
|||||
| Gastro-intestinal system / Food allergy | |||||
| chlorphenamine maleate | On Formulary | ||||
| Oral solution | |||||
| Chlorphenamine maleate (Non-proprietary) | On Formulary | ||||
|
Paediatric Oncology Local Guidelines July 14
see attached |
|||||
| sodium cromoglicate | On Formulary | ||||
| Gastro-intestinal system / Gastro-intestinal smooth muscle spasm | |||||
| dicycloverine hydrochloride | On Formulary | ||||
| Oral solution | |||||
| Dicycloverine hydrochloride (Non-proprietary) | On Formulary | ||||
| hyoscine butylbromide | On Formulary | ||||
|
HYOSCINE BUTYLBROMIDE
Hyoscine butylbromide oral doses commonly used at Barts Health: |
|||||
|
The Association of Paediatric Palliative Medicine Formulary - 2017
see attached |
|||||
| Solution for injection | |||||
| Buscopan (Sanofi Consumer Healthcare) | On Formulary | ||||
| mebeverine hydrochloride | On Formulary | ||||
| Modified-release capsule | |||||
| Colofac MR (Viatris UK Healthcare Ltd) | On Formulary | ||||
| Oral suspension | |||||
| Mebeverine hydrochloride (Non-proprietary) | On Formulary | ||||
| Gastro-intestinal system / Biliary disorders | |||||
| cholic acid | Hospital Only | ||||
| colestyramine | On Formulary | ||||
|
COLESTYRAMINE
Diarrhoea resulting from the loss of bile-salt absorption |
|||||
| ursodeoxycholic acid | On Formulary | ||||
|
NEONATAL FORMULARY VERSION 9 2016 BARTS HEALTH
|
|||||
|
CF Prescribing Pathway Final Version 5 Dec 2015 SCG
|
|||||
|
URSODEOXYCHOLIC ACID
Short Bowel Syndrome |
|||||
| Oral suspension | |||||
| Ursofalk (Dr. Falk Pharma UK Ltd) | On Formulary | ||||
|
NEONATAL FORMULARY VERSION 9 2016 BARTS HEALTH
see attached |
|||||
| Gastro-intestinal system / Hepatic encephalopathy | |||||
| lactulose | On Formulary | ||||
|
Paediatric Oncology Local Guidelines July 14
|
|||||
|
Barts Health Guideline - Management of Constipation in Children
|
|||||
|
Cystic Fibrosis & non-CF Prescribing Pathway
|
|||||
|
The Association of Paediatric Palliative Medicine Formulary - 2017
see attached |
|||||
|
LACTULOSE
https://www.nice.org.uk/guidance/cg99 |
|||||
| Oral solution | |||||
| Lactulose (Non-proprietary) | On Formulary | ||||
|
Paediatric Oncology Local Guidelines July 14
see attached |
|||||
|
Barts Health Guideline - Management of Constipation in Children
see attached |
|||||
|
The Association of Paediatric Palliative Medicine Formulary - 2015
see attached |
|||||
| Gastro-intestinal system / Oesophageal varices | |||||
| terlipressin acetate | On Formulary | ||||
|
For Hospital Use Only
|
|||||
| Solution for injection | |||||
| Terlipressin acetate (Non-proprietary) | On Formulary | ||||
|
Glypressin®
For Hospital Use Only |
|||||
| vasopressin | On Formulary | ||||
|
Synthetic vasopressin
Injection Formulation is Hospital Use Only |
|||||
| Solution for injection | |||||
| Vasopressin (Non-proprietary) | On Formulary | ||||
|
Note
Injection Formulation is Hospital Use Only |
|||||
| Gastro-intestinal system / Dyspepsia | |||||
| magnesium trisilicate with magnesium carbonate and sodium bicarbonate | On Formulary | ||||
|
MAGNESIUM TRISILICATE
For primary care only |
|||||
| sodium alginate with potassium bicarbonate | |||||
| Oral suspension | |||||
| Gaviscon Advance (Reckitt Benckiser Healthcare (UK) Ltd) | On Formulary | ||||
|
Cystic Fibrosis & non-CF Prescribing Pathway
CF & non CF Prescribing Pathway |
|||||
|
Gaviscon® Advance
For use in Primary care only |
|||||
| Gastro-intestinal system / Gastric and duodenal ulceration | |||||
| esomeprazole | Off Formulary | ||||
| Gastro-resistant tablet | |||||
| Esomeprazole (Non-proprietary) | Off Formulary | ||||
| Nexium (Grunenthal Ltd, Haleon UK Trading Ltd) | Off Formulary | ||||
| Gastro-resistant capsule | |||||
| Esomeprazole (Non-proprietary) | Off Formulary | ||||
| Emozul (Krka UK Ltd) | Off Formulary | ||||
| Powder for solution for injection | |||||
| Esomeprazole (Non-proprietary) | Off Formulary | ||||
| Nexium (Grunenthal Ltd) | Off Formulary | ||||
| lansoprazole | On Formulary | ||||
|
CF Prescribing Pathway Final Version 5 Dec 2015 SCG
|
|||||
|
Cystic Fibrosis & non-CF Prescribing Pathway
|
|||||
|
Barts Health Oral Proton Pump Inhibitor use in Children Guideline
|
|||||
|
LANSOPRAZOLE
https://pathways.nice.org.uk/pathways/acute-upper-gastrointestinal-bleeding |
|||||
|
The Association of Paediatric Palliative Medicine Formulary - 2017
see attached |
|||||
| Orodispersible tablet | |||||
| Zoton FasTab (Pfizer Ltd) | On Formulary | ||||
|
The Association of Paediatric Palliative Medicine Formulary - 2015
|
|||||
|
Barts Health Oral Proton Pump Inhibitor use in Children Guideline
|
|||||
|
Zoton®
Alternative to lansoprazole capsules |
|||||
| omeprazole | On Formulary | ||||
|
Barts Health Paediatric H pylori eradication Guideline
Seek advice from tertiary Paediatric Gastro team before initiating H pylori eradication treatment. |
|||||
|
Barts Health Oral Proton Pump Inhibitor use in Children Guideline
|
|||||
|
NEONATAL FORMULARY VERSION 9 2016 BARTS HEALTH
|
|||||
|
CF Prescribing Pathway Final Version 5 Dec 2015 SCG
|
|||||
|
Cystic Fibrosis & non-CF Prescribing Pathway
|
|||||
|
The Association of Paediatric Palliative Medicine Formulary - 2017
see attached |
|||||
|
OMEPRAZOLE
For NICE guidance on management of upper GI bleeding in children over 16 years: https://pathways.nice.org.uk/pathways/acute-upper-gastrointestinal-bleeding |
|||||
| ranitidine | On Formulary | ||||
|
CF Prescribing Pathway Final Version 5 Dec 2015 SCG
|
|||||
|
RANITIDINE
First line for gastro-oesophageal reflux disease |
|||||
|
NEONATAL FORMULARY VERSION 9 2016 BARTS HEALTH
see attached |
|||||
|
Cystic Fibrosis & non-CF Prescribing Pathway
see attached |
|||||
|
RANITIDINE
First line for gastro-oesophageal reflux disease |
|||||
|
Ranitidine Shortage Nov 2019
Please see memo for management during shortage at Barts Health |
|||||
| sucralfate | On Formulary | ||||
|
SUCRALFATE
Last line for haematemesis despite optimal treatment with other drugs |
|||||
|
The Association of Paediatric Palliative Medicine Formulary - 2017
see attached |
|||||
| Gastro-intestinal system / Gastro-oesophageal reflux disease | |||||
| esomeprazole | Off Formulary | ||||
|
ESOMEPRAZOLE
Only the injection formulation is on formulary, and is restricted for use in Paediatrics. |
|||||
|
Barts Health Oral Proton Pump Inhibitor use in Children Guideline
see attached |
|||||
| Gastro-resistant tablet | |||||
| Esomeprazole (Non-proprietary) | Off Formulary | ||||
| Nexium (Grunenthal Ltd, Haleon UK Trading Ltd) | Off Formulary | ||||
| Gastro-resistant capsule | |||||
| Esomeprazole (Non-proprietary) | Off Formulary | ||||
| Emozul (Krka UK Ltd) | Off Formulary | ||||
| Powder for solution for injection | |||||
| Esomeprazole (Non-proprietary) | Off Formulary | ||||
|
Esomeprazole
Only the injection formulation is on formulary, and is restricted for use in Paediatrics. |
|||||
|
Barts Health Oral Proton Pump Inhibitor use in Children Guideline
see attached |
|||||
| Nexium (Grunenthal Ltd) | Off Formulary | ||||
| lansoprazole | On Formulary | ||||
|
CF Prescribing Pathway Final Version 5 Dec 2015 SCG
|
|||||
|
Cystic Fibrosis & non-CF Prescribing Pathway
|
|||||
|
Barts Health Oral Proton Pump Inhibitor use in Children Guideline
|
|||||
|
LANSOPRAZOLE
https://pathways.nice.org.uk/pathways/acute-upper-gastrointestinal-bleeding |
|||||
|
The Association of Paediatric Palliative Medicine Formulary - 2017
see attached |
|||||
| Orodispersible tablet | |||||
| Zoton FasTab (Pfizer Ltd) | On Formulary | ||||
|
The Association of Paediatric Palliative Medicine Formulary - 2015
|
|||||
|
Barts Health Oral Proton Pump Inhibitor use in Children Guideline
|
|||||
|
Zoton®
Alternative to lansoprazole capsules |
|||||
| omeprazole | On Formulary | ||||
|
Barts Health Paediatric H pylori eradication Guideline
Seek advice from tertiary Paediatric Gastro team before initiating H pylori eradication treatment. |
|||||
|
Barts Health Oral Proton Pump Inhibitor use in Children Guideline
|
|||||
|
NEONATAL FORMULARY VERSION 9 2016 BARTS HEALTH
|
|||||
|
CF Prescribing Pathway Final Version 5 Dec 2015 SCG
|
|||||
|
Cystic Fibrosis & non-CF Prescribing Pathway
|
|||||
|
The Association of Paediatric Palliative Medicine Formulary - 2017
see attached |
|||||
|
OMEPRAZOLE
For NICE guidance on management of upper GI bleeding in children over 16 years: https://pathways.nice.org.uk/pathways/acute-upper-gastrointestinal-bleeding |
|||||
| sodium alginate with calcium carbonate and sodium bicarbonate | |||||
| Oral suspension | |||||
| Sodium alginate with calcium carbonate and sodium bicarbonate (Non-proprietary) | On Formulary | ||||
|
NEONATAL FORMULARY VERSION 9 2016 BARTS HEALTH
NEONATAL FORMULARY VERSION 9 2016 BARTS HEALTH |
|||||
| Peptac (Teva UK Ltd) | On Formulary | ||||
|
Cystic Fibrosis & non-CF Prescribing Pathway
CF & non-CF Prescribing Pathway |
|||||
|
Peptac®
For primary care only |
|||||
| Gastro-intestinal system / Rectal and anal disorders | |||||
| diltiazem hydrochloride | On Formulary | ||||
| Modified-release tablet | |||||
| Diltiazem hydrochloride (Non-proprietary) | On Formulary | ||||
| Retalzem (Kent Pharma (UK) Ltd) | On Formulary | ||||
| Tildiem (Sanofi) | On Formulary | ||||
| Tildiem Retard (Sanofi) | On Formulary | ||||